Associate Professor
Primary Department
Exercise & Nutrition Sciences
Affiliation
Milken Institute School of Public Health
Research Interests
Dr. Robien's group is currently studying the extent to which dietary exposure to endocrine disrupting chemicals (especially bisphenols and phthalates) is associated with doxorubicin resistance among women with triple negative breast cancer, as well as the effect of body composition (lean body mass vs. adipose tissue) on chemotherapy toxicity and treatment completion rates among patients undergoing treatment for breast cancer.
Keywords
cancer treatment, diet-chemotherapy interactions, anti-folate chemotherapy, vitamin D, blood and marrow transplantation, breast cancer,
View publications by this faculty member: